Throughout the first quarter, the Levocetirizine Dihydrochloride Prices inclined in North America on account of a continuous surge in inquiries from the pharmaceutical and healthcare sectors. Moreover, Overall inflation eased with the start of 2023 and after a significant prolonged labor shortage, owing to which the businesses in the US increased employment in January, and wages rose. Following February, the prices continued to display a similar trend and were recorded at USD 658000/MT CFR Los Angeles. Towards the termination of Q1, as inquiries from the downstream sector continued to rise, Inventories for Levocetirizine Dihydrochloride API remained low among the market players, which compelled them to focus on raising their shelves.
For more information
E-Mail:- sales@chemanalyst.com
websites:- https://www.chemanalyst.com/Pricing-data/lovocetirizine-dihydrochloride-1436
Contact No:- +13322586602
|
It is ok to contact this poster with commercial interests.
29043 hits
|
